This study evaluates a business model designed to enable efficient marketing for lipid-lowering drugs. Rising pharmaceutical marketing costs in the U.S. contribute to increasing drug prices. Our model quantifies customer insights from physician behavior and surveys to support targeted strategies. Analysis of cardiology website data categorized viewers into six groups, followed by a survey on lipid management practices. Senior cardiologists specializing in catheter treatments showed high interest in the study drug and treated complex patients. They preferred convenient information sources like medical sites over academic conferences. This model aims to reduce marketing costs and help control drug prices.
